Cargando…
Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017253/ https://www.ncbi.nlm.nih.gov/pubmed/31265606 http://dx.doi.org/10.1097/01.md.0000479949.09661.21 |
| _version_ | 1782452710800359424 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5017253 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50172532016-09-22 Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum Medicine (Baltimore) Erratum Wolters Kluwer Health 2016-01-22 /pmc/articles/PMC5017253/ /pubmed/31265606 http://dx.doi.org/10.1097/01.md.0000479949.09661.21 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
| spellingShingle | Erratum Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum |
| title | Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum |
| title_full | Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum |
| title_fullStr | Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum |
| title_full_unstemmed | Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum |
| title_short | Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment: Erratum |
| title_sort | prognostic value of serum tumor markers in medullary thyroid cancer patients undergoing vandetanib treatment: erratum |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017253/ https://www.ncbi.nlm.nih.gov/pubmed/31265606 http://dx.doi.org/10.1097/01.md.0000479949.09661.21 |